Hims & Hers Health, Inc. - Class A common stock, $0.0001 par value per share (HIMS)

Historical Holders from Q1 2020 to Q3 2025

Symbol: HIMS on NYSE
Type / Class: Equity / Class A common stock, $0.0001 par value per share
Shares outstanding: 219,713,074
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 199,726,785
Holdings value: $11,326,655,949
% of all portfolios: 0.014%
Number of holders: 503
Number of buys: 293
Number of sells: -240
Average buys %: +0.01%
Average sells %: -0.02%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Hims & Hers Health, Inc. - Class A common stock, $0.0001 par value per share (HIMS)

Filer	Ownership	Holdings Value	Nb Shares	Reporting Name	Report Period
Dudum Andrew	10.3%	$1,140,783,140	23,820,905	Andrew Dudum	07 Aug 2025
BlackRock, Inc.	10.8%	$807,569,228	23,047,067	BlackRock, Inc.	31 Mar 2025
Capital World Investors	8.6%	$888,804,973	18,559,302	Capital World Investors	30 Jun 2025
JPMORGAN CHASE & CO	8.1%	$1,009,432,170	17,796,759	JPMORGAN CHASE & CO.	30 Sep 2025

Institutional Holders of Hims & Hers Health, Inc. - Class A common stock, $0.0001 par value per share (HIMS)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	199,726,785	$11,326,655,949	+$1,433,751,186	$1,921,341,472	$1,448,389,921	$56.72	503
2025 Q2	175,272,401	$8,737,551,983	+$961,576,555	$1,617,477,298	$1,055,527,409	$49.85	501
2025 Q1	156,499,038	$4,623,681,560	-$176,903,936	$535,840,660	$402,503,123	$29.55	418
2024 Q4	164,535,250	$3,980,113,570	+$662,356,870	$304,413,150	$292,864,380	$24.18	385
2024 Q3	137,388,700	$2,532,982,313	+$13,483,116	$67,597,090	$95,628,510	$18.42	302
2024 Q2	135,555,935	$2,737,194,047	+$237,895,932	$104,065,816	$187,183,866	$20.19	291
2024 Q1	127,014,197	$1,964,665,169	+$120,987,021	$14,504,672	$33,613,216	$15.47	236
2023 Q4	124,812,595	$1,110,858,696	-$20,511,047	$9,729,480	$9,279,140	$8.9	194
2023 Q3	119,054,225	$748,816,065	-$112,963,918	$7,809,035	$8,684,603	$6.29	189
2023 Q2	132,438,140	$1,244,975,489	+$139,460,952	$8,993,184	$10,091,389	$9.4	185
2023 Q1	119,222,566	$1,182,050,601	+$138,780,557	$6,239,664	$18,982,096	$9.92	185
2022 Q4	105,528,105	$676,436,778	+$198,928,135	$2,028,717	$5,706,775	$6.41	151
2022 Q3	94,761,647	$528,756,939	+$31,959,823	$3,150,000	$4,966,000	$5.58	145
2022 Q2	89,005,896	$403,186,006	+$45,235,978	$1,312,000	$3,103,000	$4.53	132
2022 Q1	78,422,127	$417,949,018	-$13,253,687	$2,317,000	$3,295,000	$5.33	127
2021 Q4	70,024,982	$458,628,840	+$14,988,392	$3,299,000	$3,260,000	$6.55	137
2021 Q3	42,323,200	$319,091,740	-$102,457,566	$9,451,000	$8,515,000	$7.54	107
2021 Q2	54,478,149	$592,933,897	+$19,733,325	$8,005,000	$11,255,000	$10.89	84
2021 Q1	52,489,763	$692,968,615	+$689,881,615	$11,056,000	$15,004,000	$13.23	80
2020 Q4	186,615	$2,725,000	+$2,725,000			$14.6	1
2020 Q3	0	$0	-$53,000	$0	$0		0
2020 Q1	4,000	$53,000		$53,000	$519,000	$13.25	1